Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the close of an $80 million Series B financing. Cormorant Asset Management led the financing with participation from new investors Westlake Village BioPartners, Surveyor Capital (a Citadel company) and Logos Capital as well as Se-ries A investors RA Capital Management, 5AM, Kleiner Perkins, Sanofi Ventures and Novartis Ven-ture Fund. Proceeds from the financing will be used to advance the company’s small molecule RNA platform (SMIRNA™) to identify clinical candidates in myotonic dystrophy type 1 (DM1), amyo-trophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and various tauopathies.Read More
On this episode of the weekly podcast The Puck: Venture Capital & Beyond, podcast host Jim Baer talks with Managing Partner at Westlake Village BioPartners Sean Harper, MD, about his experience working on the front lines of the medical industry and the ongoing evolution of the LA Biotech Hub. They discuss Harper’s background as a … Read MoreRead More
Our firm brings Silicon Valley access and experience to Los Angeles, an emerging biotech community that is fresh, unorthodox and exciting. From Silicon Beach to some of the most successful startups in biomedical history, the City of Angels is in the midst of becoming one of the world’s biotech hubs.
We are playing our part catalyzing the biopharma industry not just in the LA region but beyond. Technology can come from anywhere and we match our company building skills with interested entrepreneurs or academic centers.
From a leadership team that combines complementary skills in science and business with a track record of developing breakthrough products and high-value companies unlike anyone else in the life sciences venture community, we are forging new paths incubating and building life sciences companies that have the potential to bring transformative therapies and technologies to patients.
We want to work with people who have that same entrepreneurial spirit and passion to help patients in need; people who seek to push the boundaries of science and technology.
What we are looking for
New technologies and therapeutic approaches. We have broad and deep scientific expertise to nurture startups in virtually any therapeutic area of medicine and in all drug modalities.
Entrepreneurs with breakthrough ideas who want partners in building companies and getting their technology to patients as soon as practicable. We are open to anything that is new and focuses on a serious unmet patient need.
Tech transfer offices who want to work with experienced drug development and company building experts to commercialize science and technology to benefit patients.
If you feel we could be a good fit for you, your team and your technology, let’s discuss how what you are developing is going to make a real difference in the lives of patients and how we can work with you to make that happen.